These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management". Patnaik MM; Tefferi A Am J Hematol; 2021 Mar; 96(3):379-394. PubMed ID: 33428785 [TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review. Fontana D; Elli EM; Pagni F; Piazza R Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370785 [TBL] [Abstract][Full Text] [Related]
10. Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features. Aqil B; Sukhanova M; Behdad A; Jennings L; Lu X; Chen Q; Chen YH; Gao J Hum Pathol; 2022 Nov; 129():81-89. PubMed ID: 36087739 [TBL] [Abstract][Full Text] [Related]
11. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management. Patnaik MM; Tefferi A Am J Hematol; 2017 Mar; 92(3):297-310. PubMed ID: 28188970 [TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future. Nathan DI; Feld J; El Jamal SM; Mascarenhas J; Tremblay D Leuk Res; 2022 Apr; 115():106820. PubMed ID: 35279478 [TBL] [Abstract][Full Text] [Related]
13. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management. Szuber N; Orazi A; Tefferi A Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693 [TBL] [Abstract][Full Text] [Related]
14. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview. Kuendgen A; Kasprzak A; Germing U Front Oncol; 2021; 11():778741. PubMed ID: 34869027 [TBL] [Abstract][Full Text] [Related]
15. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management". Patnaik MM; Tefferi A Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061 [TBL] [Abstract][Full Text] [Related]
16. Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis. Wan Z; Han B Front Oncol; 2020; 10():579221. PubMed ID: 33117717 [TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Mangaonkar AA; Lasho TL; Ketterling RP; Reichard KK; Gangat N; Al-Kali A; Begna KH; Pardanani A; Al Ali NH; Talati C; Sallman D; Padron E; Patnaik MM; Tefferi A; Komrokji R Blood Cancer J; 2022 Feb; 12(2):26. PubMed ID: 35105856 [TBL] [Abstract][Full Text] [Related]
18. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T. Talati C; Padron E Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113 [TBL] [Abstract][Full Text] [Related]
19. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Ok CY; Trowell KT; Parker KG; Moser K; Weinberg OK; Rogers HJ; Reichard KK; George TI; Hsi ED; Bueso-Ramos CE; Tam W; Orazi A; Bagg A; Arber DA; Hasserjian RP; Wang SA Mod Pathol; 2021 Jan; 34(1):20-31. PubMed ID: 32694616 [TBL] [Abstract][Full Text] [Related]